Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

Me is to cut 200 jobs in the wake of declining revenues. This company expects a proposed retructuring, affecting 40% of its ...

CEO Anne Wojcicki told investors on an earnings call Tuesday that the moves are “difficult but necessary actions that we ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...

Anne Wojcicki, 23andMe’s co-founder and chief executive, has said she intends to take the company private and will not consider a third-party takeover. “We are committed to protecting customer data ...

Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass layoffs — 40% of ...

But it’s not just staffing changes: 23andMe is also shutting down its entire therapeutics division, which had been working on ...

What is the most Silicon Valley thing about your morning routine? Zoë, you go first. Zoë Schiffer: Pretty much the first ...

23andMe, the struggling ancestry tracing company, continues to spiral, raising questions about its business prospects and what could happen to its sensitive customer genetic testing data. CEO Anne ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.